Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2001)
Procedure for the determination of fibrinogen in plasma: approved guideline, 2nd end
A. Sturk, Willy Morrien-Salomons, M. Huisman, J. Borm, H. Büller, J. Cate (1987)
Analytical and clinical evaluation of commercial protein C assays.Clinica chimica acta; international journal of clinical chemistry, 165 2-3
G. Handeland, U. Abildgaard, A. Aasen (2009)
Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.Scandinavian journal of haematology, 31 5
(2007)
NCSS, PASS and GESS
A. Erslev, A. Besarab (1997)
Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure.Kidney international, 51 3
T. Rabelink, J. Zwaginga, H. Koomans, J. Sixma (1994)
Thrombosis and hemostasis in renal disease.Kidney international, 46 2
José López, C. Kearon, Agnes Lee (2004)
Deep venous thrombosis.Hematology. American Society of Hematology. Education Program
Á. Salvatierra, R. Guerrero, Mariano Rodríguez, A. Álvarez, Fuensanta Soriano, R. Lopez‐Pedrera, R. Ramírez, J. Carracedo, F. López-Rubio, J. López-Pujol, F. Velasco (2001)
Antithrombin III Prevents Early Pulmonary Dysfunction After Lung Transplantation in the DogCirculation: Journal of the American Heart Association, 104
R. Singhal, K. Brimble (2006)
Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management.Thrombosis research, 118 3
Mary Eberst, L. Berkowitz (1994)
Hemostasis in renal disease: pathophysiology and management.The American journal of medicine, 96 2
AngelSalvatierra, RafaelGuerrero, MarianoRodriguez, AntonioAlvarez, FuensantaSoriano, RosarioLopez-Pedrera, RafaelRamirez, JuliaCarracedo, FernandoLopez-Rubio, JavierLopez-Pujol, FranciscoVelasco (2001)
Antithrombin III Prevents Early Pulmonary Dysfunction After Lung Transplantation in the DogCirculation
N. Vaziri (2006)
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.American journal of physiology. Renal physiology, 290 2
Ian Bickle, Y. Weerakkody (2017)
Protein S deficiencyRadiopaedia.org
O. Özkaya, K. Bek, T. Fışgın, Y. Aliyazicioglu, Sevinç Sultansuyu, Y. Açıkgöz, D. Albayrak, K. Baysal (2006)
Low protein Z levels in children with nephrotic syndromePediatric Nephrology, 21
GF Handeland, U Abildgaard, AO Aasen (1983)
Simplified assay for antithrombin III activity using chromogenic peptide substrateScand J Haematol, 31
F. Locatelli, L. Vecchio, C. Manzoni (1998)
Morbidity and Mortality on Maintenance HaemodialysisNephron, 80
(1994)
Hemostatic problems associated with renal disease
E. Ikkala, H. Nevanlinna (1958)
[Blood coagulation].Duodecim; laaketieteellinen aikakauskirja, 74 6
A. Çıtak, S. Emre, A. Sâirin, I. Bilge, A. Nayır (2000)
Hemostatic problems and thromboembolic complications in nephrotic childrenPediatric Nephrology, 14
The diagnosis of hypercoagulation is essential for the identification of individuals at high risk for thrombosis and for early treatment of thrombotic disorder. The objective of the study was to evaluate some parameters for assessing the prothrombotic state in dogs with chronic renal failure (CRF). Some natural anticoagulants, protein C (PC), protein S (PS), and antithrombin III (AT III), as well as fibrinogen concentration and clinical chemistries, were concentrated. The study groups consisted of 42 dogs with CRF and 34 age- and sex-matched clinically healthy control dogs. The level of AT III in the CRF group was significantly lower (P < 0.05), but the fibrinogen concentration was significantly higher (P < 0.05) than in the control group. Additionally, the cholesterol level in the CRF group was significantly higher than in the control group (P < 0.05) and was positively correlated to creatinine (R = 0.5, P < 0.05). Elevated levels of PC and PS were exhibited in eight dogs with subcutaneous edema. The increased levels of PC and PS may counterbalance the reduction of AT III and may be related to the magnitude of hypoalbuminemia and proteinuria. These seem to be preventive mechanisms against thromboembolic phenomena. Simple correlations among parameters were determined for the CRF group. The fibrinogen concentration was correlated inversely with the AT III level (R = −0.63, P < 0.05). A negative correlation between AT III and azotemic parameters (creatinine: R = −0.68, P < 0.05; blood urea nitrogen (BUN): R = −0.65, P < 0.05) was observed also. In contrast, the fibrinogen concentration was positively correlated to creatinine (R = 0.66, P < 0.05) and BUN (R = 0.67, P < 0.05). The study concluded that there was a significant reduction in AT III and hyperfibrinogenemia, which were predictable parameters for thrombotic tendency in the dogs with CRF. Hypercholesterolemia was the other risk factor.
Comparative Clinical Pathology – Springer Journals
Published: Mar 2, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.